azacitidine,quizartinib,venetoclax,cytarabine
abbvie,roche,daiichi sankyo
['aml,(-streamline),(-seamless),(-kamloops),(-dreamlike)', 'azacitidine,(-oral azaci),(-azacitidine oral)', 'ven-a-qui', 'aml,(-streamline),(-seamless),(-kamloops),(-latamleaders)', 'cytarabine', 'venetoclax']
el doctor juan miguel bergua presenta hoy en #eha2023: updated results of ven-a-qui study: a phase 1-2 trail to assess the safety and efficacy of triplets for newly diagnosed unfit aml patients: azacitidine or low-dose cytarabine with venetoclax and quirzatinib 
Grupo de investigación clínica independiente en Hematología. 
Llevamos la investigación en la sangre.
The Spanish Hematology Research Group